Meet us at the MEDICA trade fair in Düsseldorf, 11–14 November!
Dialysis
TauroLock™ solutions meet the needs of patients suffering from kidney failure.
Oncology
TauroLock™ solutions protect patients with central-venous catheters during cancer treatments.
Parenteral nutrition
TauroLock™ solutions facilitate parenteral nutrition for patients at all ages.
TauroLock™
TauroLock™ is suitable for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.
TauroLock™-HEP100
TauroLock™-HEP100 can be used for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and sustain a high patency rate.
TauroLock™-Hep500
TauroLock™-HEP500 meets the particular needs of dialysis patients. It ensures a good flow-rate and prevents catheter-related infections as well as occlusions.
TauroLock™-U25.000
TauroLock™-U25.000 provides a strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU of urokinase.
NutriLock™
NutriLock™ is a heparin- and citrate-free lock solution. Based on the antimicrobial agent taurolidine, it protects patients against catheter-related infections.
Full access
Log in or sign up to download all available materials for free
Open access
Download a selected range of materials for free
An overview of national and international recommendations for the use of lock solutions
Interview with founder Claus Herdeis
Revisiting milestones in research
How André turned an end into a beginning
Biofilm and catheter-related infections
TauroPharm
Newsletter
We'll keep you posted on upcoming events, free download materials, and research insights.
Our website uses cookies and Analytics to guarantee you the best possible user experience. You can find more information in our privacy policy.